Caricamento...
The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps
Biologic therapy is a new treatment option for patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Currently, the only biologic with Food and Drug Administration–approval status for CRSwNP is dupilumab. Several other biologics are likely to be approved for CRSwNP, including mepolizumab...
Salvato in:
| Pubblicato in: | Ear Nose Throat J |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7980424/ https://ncbi.nlm.nih.gov/pubmed/33035132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0145561320964653 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|